Search Menu

Home
HTB
2020
April
01

1 April 2020

Contents

Side effects

Dolutegravir associated with hyperglycaemia in people switching first-line ART in Uganda

HTB RSS

Early access

Vertical transmission rate below 0.3% among women living with HIV in the UK 31 October 2022
HIV Glasgow Congress 2022 31 October 2022
Metabolic complications of newer HIV drugs in older people 30 October 2022
Cabotegravir-LA submitted to EMA for use as PrEP in Europe 28 October 2022
All early access reports

Current issues

October 2022
September 2022
August 2022
Back issues

Special report

Monkeypox into Autumn: still no emergency funding, vaccine efficacy and UK declines further vaccines 3 October 2022

More from HTB

Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage

Home

i-Base homepage

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
107 The Maltings, 169 Tower Bridge Road, London SE1 3LJ.
Tel + 44 (0) 208 616 2210. Email admin@i-base.org.uk
Registered charity no: 1081905. Company reg no: 3962064.

Search i-Base

Site navigation

Quick links: HIV positive; Advocate; Professional; Donate; Feedback

Advice and information: Q and A; Phoneline; Pocket info; Guides; HIV meds; Glossary

Research and conference reports: HTB; HTB South; Pipeline report

Publications and resources: Publications; Other resources; Translations; Slide sets; Order and subscribe

News and updates: News; Blogs

Advocates' network: UK-CAB; Training manual

i-Base: About us; Contact; Sitemap; Home

Find us on Facebook